Clinical Trial Update: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of belimumab in adults with interstitial lung disease associated with connective tissue disease is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease-associated Interstitial Lung Disease

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Diseases, Interstitial | Phase 3 | Status: RECRUITING